Costim Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in Cambridge, MA and active since 2014.
Costim Pharmaceuticals Inc was established in 2014, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Robert Millman at the company’s single location by writing to 215 First St # 430, Cambridge, Massachusetts MA 02142 or by phoning (617) 945-0079. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Costim Pharmaceuticals Inc |
| Contact Person: | Robert Millman |
| Address: | 215 First St # 430, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 945-0079 |
| Website Address: | novartis.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2014 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Costim Pharmaceuticals Inc was started in 2014 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Millman for inquiries that concern Costim Pharmaceuticals Inc by calling the company number (617) 945-0079, as your correspondence is most welcome. Additionally, the physical location of the single location of Costim Pharmaceuticals Inc can be found at the coordinates 42.364203,-71.078651 as well as the street address 215 First St # 430 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Costim Pharmaceuticals Inc’s website at novartis.com and engage with its social media outlets through on Twitter and on Facebook.